RICHMOND, Va. (WRIC) — A new manufacturing process is on track to make developing HIV-prevention medication more affordable and potentially decrease new HIV infections in hard-hit countries. Virginia ...

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Human immunodeficiency virus (HIV) is a germ that causes a lifelong infection that slowly weakens the immune system. Though the infection is lifelong, medicines can keep the virus in check and help ...

Medicines that treat HIV are called antiretroviral therapy (ART). Genvoya is a combination tablet that contains the following four medicines that work together to treat HIV. Cobicistat is a “booster.” ...

Use one of the services below to sign in to PBS: You've just tried to add this video to My List. But first, we need you to sign in to PBS using one of the services below. You've just tried to add this ...

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, ...

Called “bluetoothing,” the gruesome movement is fueling a wave of new HIV infections in hotspots around the globe, including Fiji and South Africa. Doctors are warning that the surge in cases is just ...